Statistical flag only — not an accusation of fraud
⚠️ This provider averages 358 services per working day — physically unusual for an individual practitioner
Based on 896.1K total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $11.7M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 358 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 3110% from 2014 to 2023.
This provider has been statistically flagged with a risk score of 68/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 415% in 2017
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $314.52 | $79.25 | 3.97x | $235.27 | $103.7K | 1.3K | 9 |
| 2015 | $321.30 | $85.20 | 3.77x | $236.10 | $124.7K | 1.5K | 9 |
| 2016 | $183.91 | $50.48 | 3.64x | $133.43 | $53.1K | 1.1K | 14 |
| 2017 | $19.38 | $5.06 | 3.83x | $14.32 | $273.0K | 53.9K | 28 |
| 2018 | $30.54 | $6.62 | 4.61x | $23.92 | $481.5K | 72.8K | 31 |
| 2019 | $39.22 | $7.90 | 4.96x | $31.32 | $701.9K | 88.9K | 42 |
| 2020 | $49.37 | $14.14 | 3.49x | $35.23 | $2.2M | 155.1K | 54 |
| 2021 | $51.52 | $13.57 | 3.80x | $37.95 | $2.0M | 148.5K | 57 |
| 2022 | $56.88 | $14.73 | 3.86x | $42.15 | $2.5M | 166.4K | 62 |
| 2023 | $61.92 | $16.09 | 3.85x | $45.83 | $3.3M | 206.7K | 64 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 56.4K | $2.3M | $40.24 | 2.67x |
| J9299 | Injection, nivolumab, 1 mg | 67.7K | $1.6M | $22.98 | 2.52x |
| J0897 | Injection, denosumab, 1 mg | 43.0K | $679.0K | $15.80 | 2.86x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 875 | $613.6K | $701.23 | 6.08x |
| J9312 | Injection, rituximab, 10 mg | 8.0K | $547.7K | $68.57 | 3.04x |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 15.5K | $527.1K | $34.05 | 2.52x |
| J2505 | Injection, pegfilgrastim, 6 mg | 177 | $507.6K | $2.9K | 4.92x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 4.9K | $403.5K | $82.12 | 2.87x |
| J9035 | Injection, bevacizumab, 10 mg | 6.7K | $386.9K | $57.61 | 2.92x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 3.1K | $318.3K | $101.18 | 3.62x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 507 | $288.0K | $567.98 | 2.62x |
| J9173 | Injection, durvalumab, 10 mg | 4.2K | $259.0K | $62.12 | 2.33x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 4.4K | $239.5K | $54.51 | 2.61x |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 272.3K | $229.9K | $0.84 | 3.67x |
| J9022 | Injection, atezolizumab, 10 mg | 3.4K | $219.1K | $63.83 | 2.65x |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 1.9K | $197.7K | $101.68 | 10.39x |
| J9041 | Injection, bortezomib, 0.1 mg | 7.5K | $191.9K | $25.43 | 4.13x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 17.8K | $184.0K | $10.33 | 2.95x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 789 | $158.1K | $200.34 | 3.60x |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 1.0K | $156.6K | $149.53 | 7.20x |
This provider submits charges 3.87 times higher than what Medicare actually pays.
A markup ratio of 3.87x means for every $100 Medicare pays, this provider initially charges $387. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in SC for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Renwick Goldberg, MD | Myrtle Beach, SC | $38.6M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data